175 related articles for article (PubMed ID: 34595953)
1. Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies.
Academia EC; Mejías-De Jesús CM; Stevens JS; Jia LY; Yankama T; Patel C; Lee J
J Manag Care Spec Pharm; 2021 Oct; 27(10):1438-1446. PubMed ID: 34595953
[No Abstract] [Full Text] [Related]
2. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
3. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
[TBL] [Abstract][Full Text] [Related]
4. Refill-Based Medication Use Quality Measures in Kidney Transplant Recipients: Examination of Proportion of Days Covered and Medication Possession Ratio.
Hofmeyer BA; Look KA; Hager DR
J Manag Care Spec Pharm; 2018 Apr; 24(4):367-372. PubMed ID: 29578851
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis medication adherence in a health system specialty pharmacy.
Berger N; Peter M; DeClercq J; Choi L; Zuckerman AD
Am J Manag Care; 2020 Dec; 26(12):e380-e387. PubMed ID: 33315331
[TBL] [Abstract][Full Text] [Related]
6. Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies.
Zuckerman A; Crumb J; Kandah HM; Platt T; Duckworth D; Lo K; Mitchell D; Diamantides E; Streck CM; DeClercq J; Choi L; Patel R
J Manag Care Spec Pharm; 2023 Jul; 29(7):740-748. PubMed ID: 37404071
[No Abstract] [Full Text] [Related]
7. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
8. Adherence to self-administered biologic disease-modifying antirheumatic drugs across health-system specialty pharmacies.
Zuckerman AD; DeClercq J; Choi L; Cowgill N; McCarthy K; Lounsbery B; Shah R; Kehasse A; Thomas KC; Sokos L; Stutsky M; Young J; Carter J; Lach M; Wise K; Thomas TT; Ortega M; Lee J; Lewis K; Dura J; Gazda NP; Gerzenshtein L; Canfield S
Am J Health Syst Pharm; 2021 Nov; 78(23):2142-2150. PubMed ID: 34407179
[TBL] [Abstract][Full Text] [Related]
9. Navigating the Wild West of Medication Adherence Reporting in Specialty Pharmacy.
Canfield SL; Zuckerman A; Anguiano RH; Jolly JA; DeClercq J; Wascher M; Choi L; Knox S; Mitchell DG
J Manag Care Spec Pharm; 2019 Oct; 25(10):1073-1077. PubMed ID: 31556829
[TBL] [Abstract][Full Text] [Related]
10. Health-system specialty pharmacy role and outcomes: A review of current literature.
Zuckerman AD; Whelchel K; Kozlicki M; Simonyan AR; Donovan JL; Gazda NP; Mourani J; Smith AM; Young L; Ortega M; Kelley TN
Am J Health Syst Pharm; 2022 Oct; 79(21):1906-1918. PubMed ID: 35916907
[TBL] [Abstract][Full Text] [Related]
11. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
Gutenschwager DW; Patel A; Soyad AT; Patel S; Szandzik EG; Kelly B; Smith ZR
Am J Health Syst Pharm; 2024 Jan; 81(2):66-73. PubMed ID: 37611180
[TBL] [Abstract][Full Text] [Related]
12. Managing specialty medication services through a specialty pharmacy program: the case of oral renal transplant immunosuppressant medications.
Tschida S; Aslam S; Khan TT; Sahli B; Shrank WH; Lal LS
J Manag Care Pharm; 2013; 19(1):26-41. PubMed ID: 23383705
[TBL] [Abstract][Full Text] [Related]
13. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
[No Abstract] [Full Text] [Related]
14. Adherence and persistence to self-administered disease-modifying therapies in patients with multiple sclerosis: A multisite analysis.
Zuckerman AD; DeClercq J; Simonson D; Zagel AL; Turco E; Banks A; Wawrzyniak J; Rightmier E; Blevins A; Choi L
Mult Scler Relat Disord; 2023 Jul; 75():104738. PubMed ID: 37182475
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacy channel on adherence to oral oncolytics.
Stokes M; Reyes C; Xia Y; Alas V; Goertz HP; Boulanger L
BMC Health Serv Res; 2017 Jun; 17(1):414. PubMed ID: 28629454
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist.
Banks AM; Peter ME; Holder GM; Jolly JA; Markley BM; Zuckerman SL; Choi L; Nwosu S; Zuckerman AD
J Pharm Pract; 2020 Oct; 33(5):605-611. PubMed ID: 30700202
[TBL] [Abstract][Full Text] [Related]
17. Impact of a specialty pharmacy case management service on adherence in patients receiving oral antineoplastic agents.
Middendorff G; Elsey R; Lounsbery B; Chadwell R
J Oncol Pharm Pract; 2018 Jul; 24(5):371-378. PubMed ID: 28509613
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma.
Lee C; Grigorian M; Nolan R; Binder G; Rice G
J Med Econ; 2016; 19(4):397-402. PubMed ID: 26652728
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated with Adherence Rates for Oral and Intravenous Anticancer Therapy in Commercially Insured Patients with Metastatic Colon Cancer.
Seal BS; Anderson S; Shermock KM
J Manag Care Spec Pharm; 2016 Mar; 22(3):227-35. PubMed ID: 27003552
[TBL] [Abstract][Full Text] [Related]
20. Droxidopa management by an integrated health-system specialty pharmacy team.
Livezey SN; Shah NB; DeClercq J; Keefe J; Choi L; Shibao C; Zuckerman AD
J Am Pharm Assoc (2003); 2022; 62(6):1904-1911. PubMed ID: 35787811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
